Despite this ancient admonition, little has been published about the seasonal&y of bloodstream infection (BSI),' and nothing from developing countries where resources for diagnosis and treatment of life-threatening infections are limited. Without effective microbiology services, decisions to treat infections often are based on presumptive diagnoses. Given the limited availability of antimicrobial agents, it is essential that clinicians in developing countries be provided reliable information regarding the most likely pathogens that are associated with commonly diagnosed infections, and the susceptibilities of these pathogens to available antimicrobials.
Previous studies of BSI in hospitalized adults in subSaharan Africa have demonstrated varying distributions of BSI pathogens.*-' Most of these studies used limited laboratory methods, were conducted during one seasonal cycle, or included cumulative annual data that did not permit investigators to determine whether the distribution of BSI pathogens varies by season. This report presents a prospective evaluation of BSI in febrile inpatients in a teaching hospital in sub-Saharan Africa where it had already been established that the predominant pathogens causing BSI during the dry season are Streptococcus pneumoniae and Mycobacterium tuberculosis.'
MATERIALS AND METHODS

Study Area
Lilongwe Central Hospital (LCH) is the largest government regional medical center in central Malawi. It has approximately 300 beds and provides services to a patient catchment area of 230,000 citizens. During the 63 wet season, there are approximately 8 to 15 admissions to the medical service per day, and over 50% of these patients have fever. Less than 1% of newly admitted adult patients with fever have blood cultures performed. The most common diagnoses made in adult patients admitted to LCH with fever are malaria, tuberculosis, diarrhea, sepsis, or human immunodeficiency virus type 1 (HIV-l) infection.* The microbiology facilities at LCH are limited to only gram stains routinely performed on sputum or urine specimens, and examination of blood smears for malaria. Thus, many of the above admission diagnoses are never confirmed.
Patients
In the period between March 22 and May 6, 1998 (study period), all febrile (axillary temperature 237.5"C within 12 hr of admission) adults (214 y) presenting to the LCH medical service, regardless of symptoms, were evaluated by clinical officers supervised by one of the study's principal investigators. After providing informed consent, patients were interviewed and examined. The data from the history and physical examination were recorded on standardized assessment forms and included demographics, history of acute and chronic symptoms, antimicrobial therapy during the week before admission, and clinical outcome (whether patients were discharged or died). Fever, cough, weight loss, and diarrhea were deemed chronic if present for more than 1 month.
Next, venous blood was drawn for culture, blood count, HIV-l testing, and preparation of malaria smears. All patients received HIV-l pretest counselling. Human immunodeficiency virus type I test results were reported to the physician in charge of the patient's inpatient care; post-test counselling was provided to study patients with confirmed HIV-l infection.
Blood Cultures and Malaria Smears
Five milliliters of blood were inoculated into each of a pair of BACTEC TM Myco/F Lytic (MFL) blood culture bottles designed for use in the BACTEC 9000 series automated blood culture instruments (Becton Dickinson Microbiology Systems, Cockeysville, MD), another 10 mL were added to an ISOLATORTM 10 (Isolator) tube (Warnpole Laboratories, Cranbury, NJ). The Isolator tube was processed according to the manufacturer's recommendations and portions of the lysis-centrifugation concentrate were cultured for mycobacteria in a Septi-ChekTM AFB biphasic blood culture bottle (Becton Dickinson), and for fungi on inhibitory mold agar (IMA) slants, as previously described.8 All blood culture bottles and agar slants were incubated aerobically at 35°C. The MFL blood culture bottles were examined manually for growth, using a handheld ultraviolet lamp to detect fluorescence of the indicator at the bottom of the bottle. This was performed daily during the first week and then once weekly for a total of 8 weeks. Septi-Chek AFB bottles were examined once weekly for a total of 8 weeks or until growth was observed. The IMA slants were read macroscopically daily during the first week, then weekly for 4 weeks or until growth was observed. Preliminary identification of bacteria and fungi was made on site using standard microbiologic tests.
All blood culture bottles and all bacteria, fungi, or mycobacteria that were isolated from blood cultures at the study site were transported to the Clinical Microbiology Laboratory at Duke University Medical Center, where mycobacteria and fungi cultures were processed and the identities of bacteria and fungi isolates were confirmed. Mycobacterium tuberculosis complex and Mycobacterium avium complex were identified using DNA probes (AccuPROBE; Gen-Probe, San Diego, CA) and biochemical tests.
The blood culture methods, the volume of blood inoculated into the MFL vial, and onsite microbiologic methods for identification of gram-positive and gram-negative organisms, mycobacteria, and yeasts were identical to those used during the wet season study.* In addition, for both wet and dry season studies, confirmatory tests at Duke University Medical Center were performed by the same persons.
Thick blood smears were prepared for each enrolled study patient. Smears were stained using a modified Wright stain and examined microscopically for the presence of malaria parasites. In addition, smears were prepared from the blood of a randomly selected group of adult outpatient clinic attendees, who were afebrile and who were not deemed to have underlying infection.
HIV-1 Testing and Antimicrobial Susceptibility Testing
Serum samples were assayed in batches using the SUDS HIV-l and -2 enzyme-linked immunosorbent assay (ELISA) test kits (Murex Diagnostics Inc., Norcross, GA). Positive HIV-l ELISA results were repeated before reporting results to patients or physicians.
Antimicrobial susceptibility testing was performed at Duke University Medical Center according to the recommendations of the National Committee for Clinical Laboratory Standards. 9,10 Susceptibilities of gram-negative organisms to standard antimicrobial panels were tested using the Microscan' Walkaway (Baxter Diagnostics Inc., Deerfield, IL). Other susceptibilities were determined using standard disk-diffusion methods. The susceptibilities of M. tuberculosis isolates were determined using the BACTEC radiometric method (Becton Dickinson Diagnostics Instrument Systems, Sparks, MD).
Seasons and Rainfall
In Malawi, the wet season is the period between December and April; the dry season runs from May to Novem- 
Frequency n (%)
78 (32) 21 (9) 96 (40) 28 (12) 78 (33) 117 (49) 100 (42) 78 (33) 10 (4) 90 (38) 69 (29) 16 (7) 8 (3) 92 (39) 43 (18) 6 (3) 22 (9) 15 (6) 15 (6) 166 (70) 78 (33) 47 (20) ber. Records with details of the daily levels of rainfall in Lilongwe during 1997 and 1998 were obtained from a local agricultural company. These rainfall data were obtained from daily onsite measurements taken at a fixed location within 5 km of LCH.
Data Analysis and Statistics
The data from clinical assessment forms and results from blood cultures, malaria smears, and HIV-l serology were entered into a computer and analyzed using Epi Info computer software.' * The chi-squared test with Yates' correction or Fisher's exact test, where appropriate, were used to compare categoric variables. Continuous variables were compared using the Wilcoxon two-sample test. Relative risks (RR), odds ratios (OR), and 95% confidence intervals (CI) were calculated. Multivariate analysis using logistic regression was performed using SAS statistical software for personal computer (SAS Institute Inc., Gary, NC). Results from this study were compared to published BSI data obtained during the LCH 1997 dry season.'
RESULTS
During the study period, 238 consecutive, febrile adults were enrolled in the study. The median axillary temperature was 38.9"C (range, 37.5-42.O"C). The median age of study patients was 29 years (range, 14-61 y); 137 (58%) patients were female. The clinical characteristics of study patients are presented in Table 1 .
Prevalence of Bloodstream infection, HIV-l, and Malaria
Sixty-seven (28%) study patients had BSI; only one of these BSIs was polymicrobial (i.e., > 1 pathogen). Nontyphi Salmonella species, M. tuberculosis, or Cryptococcus neoformans were the three most common BSI pathogens, representing 41%, 19%, and 9% of all isolated pathogens, respectively. Only one Spneumoniae was isolated. These results varied from those reported for the 1997 dry season (Table 2) .
Of the 238 study patients, 173 (73%) were HIV-l positive; of the 67 patients with BSI, 55 (82%) were HIV-lpositive. Malaria smears were prepared for 231 study patients and 73 afebrile outpatient adult attendees. The rate of malaria parasitemia was significantly higher in the study-patient group than in the afebrile group from the outpatient clinic (72/231 [31%] vs. lo/73 [14%], RR = 2.3; 95% CI = 1.2-4.2; P < 0.01). Malaria was the presumptive diagnosis made by clinicians in 114 (48%) study patients. Of these 114 patients, 64 (56%) were presumptively treated for malaria despite having negative blood smears. Of these 64 patients, 22 (34%) had BSI; all but one (Spneumoniae) of these BSI pathogens were gramnegative bacteria. Patients with HIV-l infection were significantly more likely than those without HIV-l infection to have M. tuberculosis BSI (Table 3) ; risk of bacteremia or fungemia were not associated with patient HlV-1 status. There was no significant association between the presence of bacille Calmette-Gdrin (BCG) scars and M tuberculosis BSI.
Previous Antimicrobial Therapy and Presence of Bloodstream Infection
Logistic regression analysis revealed that oral candidiasis, chronic fever, and acute diarrhea were independently associated with BSI (Table 4) . Bloodstream infections were found in 37% (51/137) of patients with one or more of these clinical features compared with 16% (16/101> of patients without. Thus, the positive predictive value for BSI in patients having one or more of these clinical features was 37%.
A history of use of antimicrobial, antituberculous, or antimalarial agents before hospital admission was available for 221 study patients. For the week preceding hospital admission, antimicrobial use was documented in 78 (35%) of these patients. Preadmission use of antimalarial and antituberculous agents was documented in 96 (43%) and 21 (10%) patients, respectively There was no association between being on any of these therapies on admission and presence or absence of mycobacteremia, bacteremia, or fungemia.
Predictors of Inpatient Mortality
In specific types of BSI, HIV-l infection, history of Outcome data (death or discharge from hospital) were chronic cough, and a family history of cough were found available for 199 (84%) of the 238 study patients. The to be independent risk factors for mycobacteremia (see overall inpatient mortality rate in these patients was 24% Table 4 ). Mycobacteremia was found in 7% (13/178) of (47/199). Inpatient mortality was significantly higher in patients with one or more of these risk factors compared patients with BSI than in those without BSI (22/53 [420/u] with 0% (o/60) of those without. The positive predictive vs. 25/146 [17%]; P < 0.001). When stratified by type of value for mycobacteremia in patients having one or more BSI, 37% of patients with bacteremia, 36% of those with of these clinical features was 7%. There were four indemycobacteremia, and 71% of those with fungemia died pendent risk factors for bacteremia: chronic vomiting, in hospital. Although patients with HIV-l infection were acute diarrhea, jaundice, and fever over 38.9"C. Bacmore likely to die during hospitalization than patients teremia was found in 26% (39/152) of patients with one without HIV-l infection (42048 [28%] vs. 5/51 [lo%], RR or more of these risk factors compared with 8% (7/86) = 2.9; 95% CI = 1.2-6.9; P < 0.01) on multivariate analyof patients without risk factors. The positive predictive sis, independent predictors of inpatient mortality were value for bacteremia in patients having one or more of presence of any BSI (OR = 3.2; 95% CI = 1.4-7.3; P < these risk factors was 26%.
O.OOl), altered mental status (OR = 4.3; 95% CI = 1.8-9.8; 
Antimicrobial Susceptibility Testing
Of the 28 non-typhi Salmonella species that were isolated during the wet season, 15 (54%) were S. typhimurium, 4 (14%) S. enteritidis, and 9 (32%) were other serotypes. All non-typhi Salmonella species and S. typhi isolates were susceptible to chloramphenicol and ciprofloxacin. However, among the non-typhi Salmonella species isolates, there was 64% resistance to trimethoprim-sulfamethoxazole (TMP-SMX) and 73% resistance to ampicillin. Resistance to TMP-SMX and ampicillin among non-typhi Salmonella species isolates was not associated with exposure to antibacterial agents before admission to the hospital. All 13 M. tuberculosis isolates were susceptible to ethambutol, isoniazid, pymzinamide, rifampin, and streptomycin.
Rainfall
The mean monthly rainfall in the 1998 wet season during which this study was conducted was 118 mm per month. In contrast, the mean monthly rainfall during the 1997 dry season was less than 1 mm per month.
DISCUSSION
The overall BSI rate in a febrile, adult population hospitalized in a large Malawi District General Hospital during the 1998 rainy season was 28% and the three most commonly isolated pathogens were non-typhi Salmonella species (41%) M. tuberculosis (19x)), and C. neoformans (9%). The HIV-l seroprevalence rate in the study population was high (730/u), and the rates of bacteremia, mycobacteremia, and fungemia increased as the number of specific clinical predictors for each of these types of BSI increased. A previous study of an adult inpatient population at the same hospital during the 1997 dry season used the same case definition (fever), microbiologic methods, and blood culture inoculating volume, and showed similar BSI (28%) and HIV-l seroprevalence (76%) rates2 However, the BSI pathogens most commonly isolated in the dry season study were Spneumoniae (33%) and M. tuberculosis (26%).
Although seasonal variations in disease occurrence, especially for various infectious diseases, have been established by epidemiologists and clinicians over the years, few data have been documented for seasonal variation of BSI. In 1983, Flournoy and colleagues observed a seasonal pattern for Spneumoniae BSI in a United States institution-a monophasic pattern that peaked from December to April.' A search of the medical literature has revealed no published data that describe seasonal occurrence of non-typhi Salmonella bacteremia in developed or lesser developed countries. Suggested reasons for seasonal occurrence of BSI include variation in virulence of bacterial pathogens; host susceptibility; patient demographics and behavior; environmental factors, such as weather; or occurrence of underlying diseases, such as HIV-l infection. ' Previous studies in sub-Saharan Africa either were conducted during one particular season or combined data over seasonal cycles.2-'~'z Thus, seasonal variation in the distribution of BSI pathogens among inpatients in subSaharan Africa has not been previously documented. The importance of season-specific surveillance is clearly illustrated by the different recovery rates despite similar culture methods for non-typhi Salmonella and S.pneumoniae in the wet and dry seasons. These two pathogens respond to different categories of antimicrobials. In more affluent settings, initial empirical therapy would be initiated to treat a broad spectrum of potential pathogens. Then, laboratory tests would be applied to focus treatment on a specific pathogen. In many developing countries, confirmatory laboratory tests are not available or the microbiologic methods (e.g., type of media available, duration of incubation, requirements for quality control) may be inadequate. Where cost or availability prohibits the use of multiple antimicrobials, the clinician often is compelled to choose one empirical regimen. Thus, the patient's survival may depend on the clinician's awareness of the distribution of potential BSI pathogens.
To improve patient outcomes and enhance rational use of antimicrobials, hospitals in developing countries with limited laboratory resources may need to improve the accuracy of probable diagnoses and choice of antimicrobials used for initial empirical therapy. Establishing comprehensive microbiology laboratories at all hospitals in these settings may be inappropriate or unrealistic. A better approach would be identification of regional or sentinel microbiology laboratories and use of resources in these laboratories to conduct cohort-based or "probe" studies, such as the authors' study.* Cohort-based studies are conducted as periodic surveys of patients who meet simple, objective entry criteria, such as symptoms, signs (e.g., fever, diarrhea, rashes, or altered mental status), or syndromes. Cohort-based microbiologic surveillance studies, such as the authors' study, focus on quality-controlled diagnostic testing with a relatively high positive predictive value for infection, such as cultures of blood, cerebrospinal fluid, or stool, and may be more feasible and effective than continuous, individual, patient-directed laboratory testing in providing useful clinical information. In this way, the dis tribution of pathogens associated with various infections and their susceptibilities to available antimicrobials would be determined. These data could then be used to facilitate selection of the most appropriate agents for empirical therapy between study periods. In addition, these studies would provide the opportunity to enhance basic clinical microbiology capacity in sentinel regional hospitals or laboratories in need of critical public health infrastructure. In the authors' study, available resources were focused on obtaining blood cultures in a high-risk patient population using comprehensive methods to detect bacteria, mycobacteria, and fungi on site. It was documented that a relatively simple but highly efficient blood culture method can be effectively applied even in an underdeveloped setting.
Another cost-effective approach to the use of limited microbiology resources would be to base blood cultures (where resources are available) or empirical therapy on clinical predictors or syndromes. The authors' data suggest that although the positive predictive value of clinical predictors for bacteremia, mycobacteremia, or fungemia are limited in scope, they are potentially useful for the development of therapeutic or diagnostic algorithms. For example, patients presenting with acute diarrhea, vomiting, jaundice, and a high fever may be considered to be at increased risk of acquiring a BSI, probably caused by non-typhi Salmonella species, and ought to be considered for bacterial blood cultures, where these services are available, or treated with an appropriate empirical regimen. Febrile adult patients with a history of chronic cough and a family history of cough may be considered at risk of acquiring disseminated M. tuberculosis and should be examined, at least, with a chest radiograph and sputum smear.
Although differences in the prevalence of BSI may reflect different rates of HIV-l infection or differences in the stage of HIV-1 infection when patients present to the hospital, they also reflect the sensitivity of various blood culture methods used in these studies, especially for isolation of mycobacteria. Although the contribution of mycobacteremia to acute morbidity may be small, it may be necessary to assess whether the relatively large number of patients with M. tuberculosis BSI pose a significant infectious risk to others in the hospital and in their communities. The issue of hospitalized patients who do not have symptoms or signs of M. tuberculosis infection but have disseminated tuberculosis as evidenced by mycobacteremia (occult mycobacteremia) at the time of admission has recently been broached,",'" but requires further study. Identification of clinical predictors of M, tuberculosis BSI may provide an early opportunity to determine which patients have a high probability of disseminated tuberculosis and therefore should be screened early on with chest radiographs and sputum smears.
Febrile illnesses commonly are responsible for hospital admission in sub-Saharan Africa2-4~14 and often are attributed to malaria.r5 Although malaria parasitemia was significantly higher among the wet season study patients compared to the dry season study cohort (31% VS. 4%; P < O.OOl), clinical malaria was markedly overdiagnosed in both seasons.2 In the wet season, 56% of the study patients diagnosed with malaria were incorrectly diagnosed. Of these patients incorrectly diagnosed and treated for malaria, 34%, in fact, had BSIs caused almost exclusively by gram-negative organisms. Although malaria is an illness of well-known seasonal@, treatment algorithms often fail to reflect this.'",r7 Resources may be unnecessarily spent on providing empirical therapy at constant levels throughout the year for an infection whose etiologic agent varies seasonally. Studies such as this one provide location-specific confirmation of such patterns. Taking seasonal variations in disease prevalence into consideration could strengthen therapeutic algorithms for hospitalized patients with fever.
The present study had some limitations. First, only one cycle of seasons was assessed. Confirmatory assessments of seasonal variations in the etiology of BSI in hospitalized populations may need to be determined over several seasonal cycles in some countries. Second, the study population had remarkably high rates of HIV-1 seroprevalence. This underscores the potential pitfalls in applying these results to other populations that may have a lower rate of HIV-l seroprevalence, and the need for region-specific studies. Third, the study population had a high rate of pre-admission antimicrobial exposure, which nonetheless, was still lower than the dry season rate (35% wet season vs. 48% dry season; P < 0.01). However, this significant seasonal difference in antibacterial exposure preceding hospital admission did not appear to significantly affect the percentage recovery of BSI pathogens (29% wet season vs. 28% dry season; P = NS). Although the data suggest that exposure to antimicrobials before hospital admission was not associated with the presence or absence of BSI, resistance was documented among the non-typhi SalmoneZZa isolates to two antimicrobial agents that are commonly prescribed at LCH. Thus, these data further emphasize the need to control unrestricted antimicrobial use in international settings if emerging antimicrobial resistance is to be prevented.
In resource-poor countries like Malawi, antimicrobials tend to be more readily available in the outpatient or inpatient services of the larger general hospitals that people attend when they become ill. In Malawi, patients are more likely to obtain antimalarials from a community clinic for a "fever" before deciding to go to the hospital. If their illness were due to malaria, then such treatment may likely result in symptom resolution and patients would be less likely to attend the hospital. On the other hand, patients who present to the hospital with fever despite prior antimalarial therapy may, in fact, be less likely to have malaria and more likely to have other infections, such as bacteremia or pneumonia. This may partly explain why the data in the present study showed no association between prior treatment with antimalarials, antituberculous drugs, or antibacterial agents and presence or absence of BSI. When microbiology resources or infrastructure in hospitals are not adequate, clinicians remain unable to diagnose these other infections. Such conditions inevitably result in the overdiagnosis of certain infections, such as malaria, as was seen in the authors' studies.
In developed countries, confirmation of HIV-l serologic tests with Western blot molecular technique is standard in many laboratories. In contrast, there is continuing debate about the usefulness of expensive HIV-l confirmatory tests in less-developed countries where the Western blot often is not used because of its complexity and high cost. In hospitals in sub-Saharan Africa and Southeast Asia, where 50 to 75% of adults who present to hospital with fever may be HIV-l-infected,*-@ it may not be economically feasible to conduct HIV-l confirmatory testing, though a number of false HIV-positive test results would, of course, be expected. Ittiravivongs et al in Thailand, and Urassa et al in Tanzania showed that use of two enzyme-linked immunosorbent assay (ELISA) tests to confirm the presence of HIV-l antibodies produces results comparable to those of the Western blot.'8,1T This approach to confirming HIV-1 status was used effectively in Tanzania, Thailand, and Malawi.2,4.8 Thus, in a country with high prevalence rates of HIV-l infection, limited financial resources, and inadequate laboratory infrastructure, Western blot analysis for confirmation of HIV infection may not be necessary.
Data acquired in the present study are not intended for direct extrapolation to other regions or countries. Rather, the approach of regional, season-specific,"probe" surveillance studies is offered as a model for optimizing patient care where routine laboratory tests are not available. Selective application of diagnostic laboratory resources can provide answers to clinical questions that can be generalized within a region, greatly extending the effects of limited resources, improving patient care, and enhancing the recognition of emerging pathogens or antimicrobial resistance.
